Abrams Capital Management Portfolio Trends Q1 2026: Key Holdings Shifts

Abrams Capital Management's portfolio, valued at approximately $4.64 billion as of March 31, 2026, showed notable shifts in its top holdings during the recent quarter.

The most significant change was a substantial reduction in Nuvation Bio Inc. (NUVB). The position saw a massive 66.67% decrease in its share count, dropping by 2,541,009 shares. This represents a significant reduction in the fund's exposure to the biotechnology sector.

Alphabet Inc. (GOOGL) also experienced a decrease, albeit a smaller one. The fund's stake in the tech giant saw a 2.65% reduction in its share count during the quarter.

Similarly, Somnigroup International Inc. (TPX) showed a slight decrease, with a 0.09% reduction in its share count.

For more detailed information on David Abrams' investment activities, please visit the investor profile: Abrams Capital Management. You can also explore detailed company profiles for each stock held, such as Alphabet Inc. (GOOGL), Somnigroup International Inc. (TPX), and Nuvation Bio Inc. (NUVB).